Navigation Links
RCOG Completes Successful Atlanta Community Prostate Cancer Screening
Date:2/9/2009

of the lower incidences of side effects, particularly incontinence and impotence, relative to other treatment procedures.

If you have questions about prostate cancer, or to learn more about the differences between ProstRcision at Radiotherapy Clinics of Georgia and prostate cancer surgery, including robotic radical prostatectomy, visit RCOG.com and ProstRcision.com or call 1-800-952-7687.

About Radiotherapy Clinics of Georgia
Radiotherapy Clinics of Georgia is a Center of Excellence for prostate cancer treatment and research. Each year hundreds of men travel to receive prostate cancer treatment in Atlanta, Georgia from RCOG. RCOG is one of the oldest prostate seed implant programs in the world. The first prostate implant for prostate cancer at RCOG was performed in 1977, and the first patient was treated with the combination therapy now called ProstRcision in 1979. Dr. Frank Critz, founder and medical director of RCOG, developed the ProstRcision procedure and has treated more than 8,000 patients with the disease in the past 25 years. RCOG is the only source for ProstRcision, in which two forms of radiation therapy are used to destroy the prostate gland. To date, nearly 12,000 men have received treatment with ProstRcision at RCOG's seven Metro Atlanta clinics. To learn more, please visit rcog.com.

###

Read the full story at http://www.prweb.com/releases/prostate-cancer-screening/newstalk-750-wsb/prweb1971764.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. CDS Completes Large-Scale Transition of Medicare Data Processing
2. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
3. C8 Science Panel Completes Uric Acid Study
4. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
5. Johnson & Johnson Completes Acquisition of Mentor Corporation
6. Johnson & Johnson Completes Tender Offer for Mentor Corporation
7. NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase(R)) and Strengthens Clinical Leadership
8. Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered
9. InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
10. InSet Technologies Completes $25 Million Financing
11. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
RCOG Completes Successful Atlanta Community Prostate Cancer Screening
(Date:10/31/2014)... 2014 Radiology and EMR Integration ... difference between diagnostic imaging centers but Connectivity is ... DigitalOne. “Differentiation is critical in all businesses ... you consider the intense competition and the downward ... will stand-out from the competition by fully integrating ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Carving pumpkins and ... send many children to emergency rooms in the United ... holidays, Halloween had the fifth highest number of ER ... to 2007-2013 data from the National Electronic Injury Surveillance ... involved the head, noted the American Academy of Orthopaedic ...
(Date:10/31/2014)... of Health will facilitate communication among scientists, clinicians, ... from diagnosis to treatment. The Research Domain Criteria ... Institute of Mental Health (NIMH), part of NIH, ... initiative. , The aim of the RDoC ... that translates basic science into clinical settings by ...
(Date:10/31/2014)... News) -- A comparison of two of the most ... gastric bypass helped patients shed more excess pounds than ... short-term complications and long-term hospitalizations. Gastric-bypass surgery makes ... your body does not absorb all the calories from ... Health. Gastric banding is a type of weight-loss procedure ...
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, 2014 (HealthDay ... of broken bones and injured joints, a new study reports. ... percent of people who had an eczema flare-up in the past ... percent had an injury that caused a limitation of function. ... had more than double the risk of having had a fracture ...
Breaking Medicine News(10 mins):Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2Health News:Halloween at the ER Is No Treat 2Health News:NIMH creates new unit to support its research domain criteria initiative 2Health News:Study Compares 2 Common Weight-Loss Surgeries 2Health News:Study Compares 2 Common Weight-Loss Surgeries 3Health News:Eczema Tied to Bone Fracture Risk in Study 2
... Jan. 13 (HealthDay News) -- Two extra steps may improve ... , A Pap smear is the standard test, but findings ... of the National Cancer Institute call for patients to ... after the Pap smear if they have HPV infections. , ...
... shows value of exercise in treating peripheral arterial disease , , ... that a planned program of walking is good for people ... should check the results of a new U.S. government-funded study. ... of whom didn,t have the pain that is the classic ...
... suggests , , TUESDAY, Jan. 13 (HealthDay News) -- Women calling ... to the hospital after an emergency medical services team had ... , It,s not clear why this was the case, but ... heart attacks. In particular, differences in initial symptoms could explain ...
... National Alliance for Caregiving Call on the New Congress ... CaregiversSAN MATEO, Calif., Jan. 13 There are more ... family members and loved ones: an aging or ailing ... spouse with Alzheimer,s, a sibling with a traumatic war ...
... from White,women on a range of worries about workplace, education and ... decade cited by greater,proportions of Black women than White women include: ... (84 % vs. 68 %), -- Unequal pay ... (72% vs. 57%), -- Limited opportunities for job ...
... S&R Communications Group has entered,a strategic partnership with ... for chorea associated with Huntington,s,disease (HD). Xenazine is ... any HD-related symptom. , ... to help Ovation launch,Xenazine," said S&R President Paul ...
Cached Medicine News:Health News:Walking Is Good for Blocked Leg Arteries 2Health News:Women With Heart Attack Symptoms See Delays in Care 2Health News:Women With Heart Attack Symptoms See Delays in Care 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 2Health News:Caregivers Need a Bailout Too! (or 1% for Families) 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 4Health News:Caregivers Need a Bailout Too! (or 1% for Families) 5Health News:Caregivers Need a Bailout Too! (or 1% for Families) 6Health News:YWCA Survey Shows Greater Economic Concerns Among Black Women Than White Women 2
(Date:10/31/2014)... 2014  Encision Inc. (OTCQB:ECIA), a medical device company ... burns in minimally invasive surgery, today announced financial results ... 2014. The Company posted quarterly net revenue ... $414 thousand, or $(0.04) per share. These results compare ... loss of $50 thousand, or $(0.01) per share, in ...
(Date:10/31/2014)... , Oct. 30, 2014 Electronic ... electronic transmission of prescription related information between ... system allows a physician and nurse practitioner ... a medication error occurs during pharmacy operations. ... applications. It provides complete medical lists, conducts ...
(Date:10/30/2014)... , Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... company that designs, manufactures and markets innovative therapeutic ultrasonic ... announced today that it will report financial results for ... 6, 2014. The Company has scheduled a conference call ... pm ET to review the results. ...
Breaking Medicine Technology:Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2
... Resources, one of the world,s leading research and ... that, in 2008, human epidermal growth factor receptor ... Herceptin and GlaxoSmithKline/Nippon Kayaku,s Tykerb/Tyverb -- were the ... uptake of Herceptin and Tykerb/Tyverb and the expected ...
... -- Chindex International, Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent ... of China, today,announced results for the second quarter and first half ... Financial Highlights:, -- Revenue in the second ... a year over year basis;, ...
Cached Medicine Technology:Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11
... BchiVac V-500 with Vacuum Controller V-800 and water-cooled ... from Model V-500 is a ... most vacuum applications. Applications Ideally ... evaporators Laboratory vacuum source for instruments ...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... Electronic switching mechanism turns V-500 on and off as ... Model V-500 is a powerful PTFE membrane vacuum pump ... Ideally suited for use with up to two ...
... Combines BchiVac V-500 and water-cooled secondary condenser ... is a powerful PTFE membrane vacuum pump ... Applications Ideally suited for use ... Laboratory vacuum source for instruments including ...
... The Universal Vacuum System UVS400 is a ... The UVS400 combines a refrigerated vapor trap ... a single integrated unit. The easy-to-use, wide-mouth ... solvent into single jar for easy disposal. ...
Medicine Products: